Return to search

Kriya Therapeutics procures $80.5m Series A

Kriya Therapeutics, a gene therapy firm, has raised $80.5 million in Series A financing.

Kriya Therapeutics, a gene therapy firm, has raised $80.5 million in Series A financing. The investors included QVT, Dexcel Pharma, Foresite Capital, Bluebird Ventures, Narya Capital, Amplo, Paul Manning, and Asia Alpha.

Source: Press Release